22 April 2019 - There are many reasons why drug prices are so high, beginning with the fact that it costs a lot of money to develop new drugs and test them for safety and efficacy. 

Neither of these can be easily remedied while ensuring that we do not deter research and development, so most proposals to reduce drug prices amount to little more than ineffective gimmicks.

In the last few weeks we have seen multiple hearings on Capitol Hill examining the issue of drug pricing, the markup of multiple bills in the House of Representatives, and the deadline for public comments on the recent proposal by the Department of Health and Human Services to prohibit pharmacy benefit managers from negotiating rebates from pharmaceutical companies under Medicare Part D recently expired. The issue is clearly ripe for some sort of action.

Read Forbes article